BioTuesday: What’s New with Biomarkers
The line-up of expert speakers will share their knowledge on current uses, challenges, future developments and applications of biomarker, including:
- What are the most successfully applied biomarkers?
- What are the current technical limitations of using biomarkers?
- The role that biomarkers play in regulatory decision making
- How are companies developing biomarker strategies to de-risk and accelerate pre-clinical and clinical development?
- What are the current barriers to clinical adoption of biomarkers?
Dr Peter Simpson, our Chief Scientific Officer, will be delivering a keynote.